ctns-rd-04
Gene therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 8, 2019 (NCT03897361)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CystinosinSupplementation
supplementation - CTNS
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03897361 | Phase 1/Phase 2 (Phase 2) | Jul 8, 2019 | California Institute for Regenerative Medicine (CIRM), Cystinosis Research Foundation, University of California, San Diego |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Cystinosis Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of California, San Diego | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1